Prestige CEO Tightens Focus On OTCs, Considers Divesting Personal Care
This article was originally published in The Rose Sheet
Executive Summary
Prestige Brands Holdings may look to divest its entire personal care segment to sharpen its focus on its OTC drug and household products, new CEO Matt Mannelly told analysts in a Nov. 5 earnings call
You may also be interested in...
Retailer Boots' Business Development Head Touts Recession Opportunities
Recessions bring slumping revenues and workforce lay-offs, but they also can provide growth opportunities for firms willing to "take a bit of risk," according to an executive for a leading European pharmacy and retail chain
Retailer Boots' Business Development Head Touts Recession Opportunities
Recessions bring slumping revenues and workforce lay-offs, but they also can provide growth opportunities for firms willing to "take a bit of risk," according to an executive for a leading European pharmacy and retail chain
Prestige Brands Replaces CEO Due To Differences With Board
Prestige Brands Holdings' second change of CEO in three years may raise questions, but could help the company rebuild, a market analyst says